Joanna Kałafut

13PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyEvolutionary computationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 15, 2025
MM-129 Counteracts 5-Fluorouracil-Induced Cellular Senescence in Colon Cancer via SIRT1/STAT3 Signaling Pathway.

Hubert Klepacki, Beata Sieklucka, Joanna Kalafut

|Sep 25, 2024
New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells.

Iwona Rzeszutek, Martyna Cybularczyk-Cecotka, Anna Deręgowska

|Jan 11, 2024
Assessment of an Anticancer Effect of the Simultaneous Administration of MM-129 and Indoximod in the Colorectal Cancer Model.

Iwona Kwiatkowska, Justyna Magdalena Hermanowicz, Robert Czarnomysy

|Oct 14, 2023
Estrogen Receptor Signaling in Breast Cancer.

Paulina Miziak, Marzena Baran, Ewa Błaszczak

|Sep 28, 2023
Modulation of Notch Signaling by Small-Molecular Compounds and Its Potential in Anticancer Studies.

Arkadiusz Czerwonka, Joanna Kałafut, Matthias Nees

|Sep 11, 2023
Synthetic circuits based on split Cas9 to detect cellular events.

Alicja Przybyszewska-Podstawka, Jakub Czapiński, Joanna Kałafut

Pageof 3

Frequent Collaborators

8 joint publications

Adolfo Rivero-Müller

7 joint publications

Alicja Przybyszewska-Podstawka

3 joint publications

Justyna Magdalena Hermanowicz

2 joint publications

Michał Kiełbus